Eric D. Shaff, CFO and EVP at Seres Therapeutics, Inc. (MCRB), sold 5,473 shares at $24.07 ($132K) on 2016-03-28, disclosed to the SEC on 2016-03-29.
Scheduled sale ($132k) by CFO and EVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MCRB | SELL | 2026-02-18 | $2K | — | Filing → |
| MCRB | SELL | 2025-11-18 | $4K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $4K | — | Filing → |